BioSenic

Company Overview

BioSenic SA is a cutting-edge biotechnology company specializing in developing and commercializing innovative healthcare and environmental sustainability solutions. Founded in 2006, BioSenic SA has quickly established itself as a leader in its field, driven by a commitment to scientific excellence and technological innovation.

At BioSenic SA, the primary focus in cell therapy revolves around harnessing the potential of stem cells and other cellular materials to engineer novel therapeutic interventions. Through rigorous R&D efforts, the company aims to develop personalized and precision-based treatments for various diseases and disorders, including but not limited to cancer, neurodegenerative diseases, autoimmune disorders, and cardiovascular conditions. The company’s approach to cell therapy involves the development of advanced biosensors and diagnostic platforms that enable the precise characterization, isolation, and manipulation of therapeutic cells. By leveraging state-of-the-art technologies, including microfluidics, gene editing, and high-throughput screening, we strive to optimize the production process and enhance the efficacy and safety of cell-based therapies.

Financial Highlights (FY 2023)

Company's Business Segments

• Product : ArsciMed, ALLOB, JTA-004, Others
• Service : ATO - ArsciMed - intravenous, OATO – ArsciCor - oral, Cell therapy